Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1965 1
1967 4
1968 2
1971 2
1972 1
1973 2
1975 1
1978 1
1980 3
1981 1
1982 4
1983 11
1984 7
1985 5
1986 7
1987 8
1988 10
1989 13
1990 13
1991 12
1992 9
1993 10
1994 6
1995 7
1996 3
1997 4
1998 1
1999 1
2000 5
2001 2
2002 3
2003 2
2006 6
2007 1
2008 1
2009 1
2010 1
2011 6
2012 2
2013 6
2014 4
2015 5
2016 9
2017 10
2018 11
2019 6
2020 7
2021 22
2022 11
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

255 results
Results by year
Filters applied: . Clear all
Page 1
Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II): The Trans Tasman Radiation Oncology Group 13.01 Phase 2 Randomized Clinical Trial.
Siva S, Bressel M, Mai T, Le H, Vinod S, de Silva H, Macdonald S, Skala M, Hardcastle N, Rezo A, Pryor D, Gill S, Higgs B, Wagenfuehr K, Montgomery R, Awad R, Chesson B, Eade T, Wong W, Sasso G, De Abreu Lourenco R, Kron T, Ball D, Neeson P; Stereotactic Ablative Fractionated Radiotherapy Versus Radiosurgery for Oligometastatic Neoplasia to the Lung (SAFRON) II Study Investigators. Siva S, et al. Among authors: pryor d. JAMA Oncol. 2021 Oct 1;7(10):1476-1485. doi: 10.1001/jamaoncol.2021.2939. JAMA Oncol. 2021. PMID: 34455431 Free PMC article. Clinical Trial.
Australasian Gastrointestinal Trials Group (AGITG) and Trans-Tasman Radiation Oncology Group (TROG) Guidelines for Pancreatic Stereotactic Body Radiation Therapy (SBRT).
Oar A, Lee M, Le H, Hruby G, Dalfsen R, Pryor D, Lee D, Chu J, Holloway L, Briggs A, Barbour A, Chander S, Ng SP, Samra J, Shakeshaft J, Goldstein D, Nguyen N, Goodman KA, Chang DT, Kneebone A. Oar A, et al. Among authors: pryor d. Pract Radiat Oncol. 2020 May-Jun;10(3):e136-e146. doi: 10.1016/j.prro.2019.07.018. Epub 2019 Nov 21. Pract Radiat Oncol. 2020. PMID: 31761541
Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma-The RAPPORT Trial.
Siva S, Bressel M, Wood ST, Shaw MG, Loi S, Sandhu SK, Tran B, A Azad A, Lewin JH, Cuff KE, Liu HY, Moon D, Goad J, Wong LM, LimJoon M, Mooi J, Chander S, Murphy DG, Lawrentschuk N, Pryor D. Siva S, et al. Among authors: pryor d. Eur Urol. 2022 Apr;81(4):364-372. doi: 10.1016/j.eururo.2021.12.006. Epub 2021 Dec 23. Eur Urol. 2022. PMID: 34953600 Clinical Trial.
Ischemic mitral regurgitation.
Rankin JS, Hickey MS, Smith LR, Muhlbaier L, Reves JG, Pryor DB, Wechsler AS. Rankin JS, et al. Among authors: pryor db. Circulation. 1989 Jun;79(6 Pt 2):I116-21. Circulation. 1989. PMID: 2655971 Review.
Moderate hypofractionation for prostate cancer: A user's guide.
Pryor DI, Turner SL, Tai KH, Tang C, Sasso G, Dreosti M, Woo HH, Wilton L, Martin JM. Pryor DI, et al. J Med Imaging Radiat Oncol. 2018 Apr;62(2):232-239. doi: 10.1111/1754-9485.12703. Epub 2018 Jan 16. J Med Imaging Radiat Oncol. 2018. PMID: 29336109 Review.
Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensus.
Maharaj AD, Lubel J, Lam E, Clark PJ, Duncan O, George J, Jeffrey GP, Lipton L, Liu H, McCaughan G, Neo EL, Philip J, Strasser SI, Stuart K, Thompson A, Tibballs J, Tu T, Wallace MC, Wigg A, Wood M, Zekry A, Greenhill E, Ioannou LJ, Ahlenstiel G, Bowers K, Clarke SJ, Dev A, Fink M, Goodwin M, Karapetis CS, Levy MT, Muller K, O'Beirne J, Pryor D, Seow J, Shackel N, Tallis C, Butler N, Olynyk JK, Reed-Cox K, Zalcberg JR, Roberts SK. Maharaj AD, et al. Among authors: pryor d. Hepatol Commun. 2022 Nov;6(11):3260-3271. doi: 10.1002/hep4.2089. Epub 2022 Sep 25. Hepatol Commun. 2022. PMID: 36153817 Free PMC article. Review.
IL-33 priming amplifies ATP-mediated mast cell cytokine production.
Straus DB, Pryor D, Haque TT, Kee SA, Dailey JM, Jackson KG, Barnstein BO, Ryan JJ. Straus DB, et al. Among authors: pryor d. Cell Immunol. 2022 Jan;371:104470. doi: 10.1016/j.cellimm.2021.104470. Epub 2021 Dec 17. Cell Immunol. 2022. PMID: 34942481
255 results